SCHEMBL9502459

SCHEMBL9502459

CCCCCCCCCCOc1ccc(C(=O)Nc2cc(C(=O)OCCOC)ccc2SC)cc1

nearest known ligand 0.72

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ACAT1 P24752 1/20 0.72
PLK1 P53350 4/20 0.54
NR1H4 Q96RI1 2/20 0.47
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
KMT2A Q03164 1/20 0.45
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9503247 0.95 ACAT1 (0.76) ACAT1PLK1NR1H4LMNAMAPT
SCHEMBL9502352 0.92 ACAT1 (0.77) ACAT1PLK1NR1H4LMNAMAPT
SCHEMBL9503257 0.91 ACAT1 (0.60) ACAT1PLK1NR1H4LMNAMAPT
SCHEMBL9504200 0.89 ACAT1 (0.67) ACAT1PLK1NR1H4LMNAMAPT
SCHEMBL9502479 0.87 ACAT1 (0.80) ACAT1PLK1NR1H4TP53TSHR
SCHEMBL9505673 0.87 ACAT1 (0.67) ACAT1PLK1NR1H4LMNAMAPT
SCHEMBL9365882 0.86 ACAT1 (0.89) ACAT1PLK1NR1H4MAPK1KMT2A
SCHEMBL9365182 0.86 ACAT1 (0.89) ACAT1PLK1NR1H4MAPK1KMT2A
SCHEMBL9361218 0.86 ACAT1 (0.89) ACAT1PLK1NR1H4MAPK1KMT2A
SCHEMBL9361187 0.84 ACAT1 (1.00) ACAT1PLK1NR1H4MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992003408-A1 BENZANILIDE DERIVATIVES AND THEIR USE AS ANTI-ANTHEROSCLEROTIC AGENTS RHONE-POULENC RORER LIMITED (GB) 1992-03-05 WO claimed
EP-0543884-A1 BENZANILIDE DERIVATIVES AND THEIR USE AS ANTI-ATHEROSCLEROTIC AGENTS RHONE-POULENC RORER LIMITED (GB) 1993-06-02 EP disclosed
WO-1992003408-A1 BENZANILIDE DERIVATIVES AND THEIR USE AS ANTI-ANTHEROSCLEROTIC AGENTS RHONE-POULENC RORER LIMITED (GB) 1992-03-05 WO disclosed